1980
DOI: 10.1016/0360-3016(80)90244-8
|View full text |Cite
|
Sign up to set email alerts
|

A clinical trial for advanced cervico-vaginal pelvic carcinomas using californium CF-252 fast neutron therapy: Report of early responses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1982
1982
2017
2017

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…NBT is a form of high-LET radiotherapy that has been shown to be effective in killing radio-resistant cancer cells [ 5 , 7 ]. In 1979, Maruyama et al [ 20 ] published the first therapeutic results of the application of 252 Cf NBT combined with external gamma-ray radiation for the intracavitary treatment of cervix cancer. Several studies have shown that 252 Cf NBT, as a treatment of cervical cancer, is significantly more effective than conventional low-LET irradiation [ 14 , 18 , 21 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…NBT is a form of high-LET radiotherapy that has been shown to be effective in killing radio-resistant cancer cells [ 5 , 7 ]. In 1979, Maruyama et al [ 20 ] published the first therapeutic results of the application of 252 Cf NBT combined with external gamma-ray radiation for the intracavitary treatment of cervix cancer. Several studies have shown that 252 Cf NBT, as a treatment of cervical cancer, is significantly more effective than conventional low-LET irradiation [ 14 , 18 , 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…The RBE of the neutron component of 252 Cf for the tumor tissue was estimated to be 6 [ 18 20 ]. The doses at point A were calculated assuming a high-dose-rate delivery of 6 Gy-eq for each patient per fraction, administered once per week, to deliver a total dose of 30 Gy.…”
Section: Methodsmentioning
confidence: 99%
“…With the use of 252 Cf for intracavitary therapy, this combined procedure is influenced by the qualitatively different natures and effects of these two radiation types -high LET (intracavitary 252 Cf radiation) and low LET (gamma radiation, both external-beam and brachytherapy) -and is further influenced, during external-beam irradiation, by hypoxic conditions. The complexity of this new combined procedure was demonstrated for the first time in a clinical setting by Maruyama [16][17][18] and our clinical-experimental trial [32,33,36,40,41].…”
Section: Discussionmentioning
confidence: 99%
“…There has been a renewed interest in the utilization of radioactive needle implants to boost the radiation and remotecontrolled intracavity devices, e.g., Cathetron (TEM, United Kingdom), have been employed to provide intense local i r r a d i a t i~n .~~.~~ Attempts to overcome the relative radioresistance of hypoxic, potentially viable, tumor cells that may be more prominent in tumors with microscopic areas of necrosis, have included the utilization of hyperbaric oxygen,"' hypoxic cell sensitizers," and high linear energy transfer radiation^.^^ Ongoing clinical trials have suggested slight improvement in local control rates for patients treated with a combination of neutron and photon irradiation for locally advanced carcinoma of the cervix, when compared with external beam radiation utilizing photons alone.69 Intracavity placement of the neutron emitter Californium-252 has also yielded encouraging preliminary results. 68 Microwave-induced regional hyperthermia, in conjunction with external beam radiation therapy, has shown promise in a small series of patients with advanced cervical cance~s.~' Furthermore, very dramatic local tumor control rates in pelvic malignancies have been reported, utilizing radiofrequency induced local hyperthermia immediately preceeding interstitial radiation the rap^.^' The need for randomized controlled studies employing hyperthermia in conjunction with radiation therapy, is now manditory to substantiate these exciting preliminary findings.…”
Section: Cancer Of the Uterine Cervixmentioning
confidence: 99%